Cell And Gene Therapy Videos

  1. Scale Your Viral Vector Production With A Streamlined Bioreactor System 11/4/2025

    Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.

  2. Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment 11/4/2025

    Explore filtration strategies that improve viral vector yield and quality, with insights on AAV and lentivirus workflows, plus practical guidance for implementing PUPSIT in line with requirements.

  3. How To Select The Right Bioanalysis CRO For Your Program 11/3/2025

    The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?

  4. The Future Of Gene Therapy Production: Enriching Full Capsids, Reducing Costs 10/29/2025

    Explore how intensified upstream processing enriches full AAV capsids, reduces impurities, and lowers manufacturing costs. Learn how extended culture duration drives better outcomes.

  5. Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches 10/22/2025

    Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.

  6. Pace Life Sciences Capacity Update October 2025: Fill/Finish 10/20/2025

    Our experts and investment in state-of-the-art development and manufacturing facilities underscore our commitment to advancing programs from the clinic to commercialization.

  7. The Future Of Lentiviral Vector Innovation And Access 10/17/2025

    Founded on lentiviral vector design and manufacturing excellence, VBM and the LENTIVERSE™ technology platform provide a full suite of tools to quickly deliver state-of-the-art therapies and develop next-generation products.

  8. Minaris Advanced Therapies Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    During this session, we will provide an overview of our capabilities, including our contract testing services, and an update on our current capacity.

  9. Ascend & ABL Inc. Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    Operating from state-of-the-art GMP facilities, we provide end-to-end services to commercial, academic, and government clients, spanning process innovation through development, GMP manufacturing, QC testing, to aseptic fill/finish.

  10. Andelyn Biosciences Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    A risk-based framework for identity testing of ancillary raw materials in gene therapy is presented, with emphasis on implementation based on product contact, material classification, and manufacturing stage.